Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary

CompletedOBSERVATIONAL
Enrollment

2,153

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
SchizophreniaAffective Symptoms
Trial Locations (53)

Unknown

Research Site, Agárd

Research Site, Baja

Research Site, Barcs

Research Site, Berettyóújfalu

Research Site, Bicske

Research Site, Bonyhád

Research Site, Budapest

Research Site, Cegléd

Research Site, Debrecen

Research Site, Dombóvár

Research Site, Dunaújváros

Research Site, Esztergom

Research Site, Érd

Research Site, Gyöngyös

Research Site, Győr

Research Site, Gyula

Research Site, Hatvan

Research Site, Heves

Research Site, Hódmezővásárhely

Research Site, Izsófalva

Research Site, Jánoshalma

Research Site, Jászberény

Research Site, Kalocsa

Research Site, Karcag

Research Site, Kecskemét

Research Site, Kiskunhalas

Research Site, Kiskunmajsa

Research Site, Kistarcsa

Research Site, Kistokaj

Research Site, Makó

Research Site, Miskolc

Research Site, Mosonmagyaróvár

Research Site, Nagykanizsa

Research Site, Nagykálló

Research Site, Oroszlány

Research Site, Pápa

Research Site, Pécs

Research Site, Pomáz

Research Site, Salgótarján

Research Site, Sátoraljaújhely

Research Site, Sopron

Research Site, Szeged

Research Site, Szeghalom

Research Site, Szekszárd

Research Site, Szentendre

Research Site, Szentes

Research Site, Székesfehérvár

Research Site, Szigetszentmiklós

Research Site, Szolnok

Research Site, Szombathely

Research Site, Tószeg

Research Site, Vác

Research Site, Veszprém

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY